MICHAEL MCMULLEN: Open Payments
NPI 1528485026 · NEW CASTLE, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$343 in 15 payments from 6 companies in 2025. Trend: 2023 $4,164 · 2024 $365 · 2025 $343
Food & beverage: $343
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 6 | $167 |
| Lundbeck LLC | 3 | $59 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $41 |
| Teva Pharmaceuticals USA, Inc. | 2 | $38 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $22 |
| Indivior Inc. | 1 | $16 |
Products named: REXULTI, TRINTELLIX, UZEDY, CAPLYTA, SUBLOCADE.
Industry payments across PA — which companies pay providers there.
